> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Injunction Sought Against Innovative BioDefense
- URL: https://www.fdaweb.com/injunction-sought-against-innovative-biodefense/
- Published: 2018-06-06T12:00:00.000Z
- Updated: 2026-09-15T00:11:03.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5141623

FDA has filed a complaint seeking a permanent injunction against Innovative BioDefense (Lake Forest, CA) and president/CEO **Colette Cozean** to prohibit them from selling Zylast topical antiseptics with claims that they are effective against infection by pathogens such as norovirus, rotavirus, flu virus, methicillin-resistant *staphylococcus aureus* and Ebola. “Claims that a hand sanitizer can protect consumers against infection from pathogens are drug claims and therefore, these products are regulated by the FDA as drugs,” an [agency notice](https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm610146.htm?ref=fdaweb.com) says. “These products from Innovative BioDefense, Inc. have not been proven to be safe and effective for these uses and are not approved by the FDA.”

  
In 2015, FDA and the Federal Trade Commission sent a [joint Warning Letter](http://email.prnewswire.com/wf/click?upn=jxvag0QJiYRem0F0ujAq9kCBr3u2CG3l0py14PpiS-2BYHbv2jX3iRiNIok5HLb2z-2FIii9l2XUFJvG0vdfa8-2BNpU-2B7IL7Hf9Q3Ya5AvU3f6isjq0pDN5yKkK45kLUE-2Fz3FqxxBHv5bnYFFZLPeqgqKoOVJ9SLjfAV1eXGpKcHPEyaNyULuYE4-2BvVQ5eAeYzFKqfoOf203jsBSUn9fjTpttgRTduEmVTLJCrk5clvitZZjm2RlbxkKcjKuoEi3URpMNo-2F1fLbJlwNeB9Ap4EUT4b2yUcUq9ZuVrR4eDkMfb4Fc-3D%5FnE9rxSXA5G4kxsTVkgv43tTJnmhvULg8vMtvbdZHwXEle6c6tqdvw12Z3skft0RuqdJ5Agqf9RWBR0RP-2BtWWr-2Fs446MAIN3vT7rg5myIiM9HDl-2BveHeOgOl4tXaomwDhTCy8F0hSUEHdCLcHdhR-2BQ8p6pniTZS4dvtQ7XTrkQny11mNBSJCVHnDSYENG77hc8lb9fGB49uCridLaEfqMYZysBK8B4k5YoSW5R1Jt6O-2B4bV-2Bf8u9T-2B6WRrpJgd0SjQuMVsBLsfEKaYlP8o9CSrN2zJKmN0KRrPvM5BRnas5bYQtUj390bP5sQA1fA3ggD&ref=fdaweb.com) to Innovative BioDefense about the Zylast products. “Despite being warned by the FDA about their unproven claims, this company has continued to market their products as a tool for preventing infection from serious disease-related pathogens, without adequate evidence to support these uses,” said FDA Commissioner **Scott Gottlieb**.